Rchr
J-GLOBAL ID:200901008465474059   Update date: Aug. 15, 2023

Beppu Takaaki

ベップ タカアキ | Beppu Takaaki
Affiliation and department:
Job title: Neurosurgery, Hyperbaric Medicine
Research field  (3): Neurosurgery ,  Tumor diagnostics and therapeutics ,  Tumor diagnostics and therapeutics
Research keywords  (6): carbon monoxide poisoning ,  PET ,  MRI ,  malignant glioma ,  hypoxia ,  brain tumor; diagnosis; treatment; hyperbaric medicine
Research theme for competitive and other funds  (14):
  • 2020 - 2023 Identification of highly densed areas of glioma-stem cells in glioblastoma.
  • 2019 - 2022 超高磁場MRIを用いた脳脊髄液動態評価による病態診断法の開発
  • 2017 - 2019 Crarification of promissing prognositic factor during progressive brain damage after carbon monoxide poisoning
  • 2015 - 2018 Developement of new non-invasive method based on diffusion-weighted imaging for the radiographic diagnosis
  • 2014 - 2016 一酸化炭素中毒超急性期・急性期における予後予測法の確立と病態メカニズムの解明
Show all
Papers (104):
  • Kei Kitakami, Takaaki Beppu, Yuichi Sato, Akira Kurose, Kuniaki Ogasawara. Utility of arterial spin labeling for objective assessment of intratumoral microvessels in diffuse hemispheric glioma, H3 G34R-mutant: A case report and literature review. Radiology case reports. 2023. 18. 3. 856-861
  • Takaaki Beppu, Takeshi Iwaya, Yuichi Sato, Jun-Ichi Nomura, Kazunori Terasaki, Toshiaki Sasaki, Noriyuki Yamada, Shunrou Fujiwara, Tamotsu Sugai, Kuniaki Ogasawara. PET With 11C-Methyl-l-Methionine as a Predictor of Consequential Outcomes at the Time of Discontinuing Temozolomide-Adjuvant Chemotherapy in Patients With Residual IDH-Mutant Lower-Grade Glioma. Clinical nuclear medicine. 2022. 47. 7. 569-574
  • Kenichiro Asano, Yoji Yamashita, Takahiro Ono, Manabu Natsumeda, Takaaki Beppu, Kenichiro Matsuda, Masahiro Ichikawa, Masayuki Kanamori, Masashi Matsuzaka, Akira Kurose, et al. Clinicopathological risk factors for a poor prognosis of primary central nervous system lymphoma in elderly patients in the Tohoku and Niigata area: a multicenter, retrospective, cohort study of the Tohoku Brain Tumor Study Group. Brain tumor pathology. 2022
  • Kenichiro Asano, Yoji Yamashita, Takahiro Ono, Manabu Natsumeda, Takaaki Beppu, Kenichiro Matsuda, Masahiro Ichikawa, Masayuki Kanamori, Masashi Matsuzaka, Akira Kurose, et al. The Real-World status and risk factors for a poor prognosis in elderly patients with primary central nervous system malignant lymphomas: a multicenter, retrospective cohort study of the Tohoku Brain Tumor Study Group. International journal of clinical oncology. 2022. 27. 1. 77-94
  • Yoshitaka Narita, Yoshihiro Muragaki, Naoki Kagawa, Katsunori Asai, Motoo Nagane, Masahide Matsuda, Keisuke Ueki, Junichiro Kuroda, Isao Date, Hiroyuki Kobayashi, et al. Safety and efficacy of depatuxizumab mafodotin in Japanese patients with malignant glioma: A nonrandomized, phase 1/2 trial. Cancer Science. 2021. 112. 12. 5020-5033
more...
MISC (31):
more...
Professional career (2):
  • (BLANK)
  • (BLANK)
Association Membership(s) (3):
日本脳腫瘍学会 ,  日本脳神経外科コングレス ,  日本脳神経外科学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page